News Item

Dr. Mark Goldberg Presents PlantForm Corporation Inc.

Posted on Sunday, June 20th 2010   

As an example of how a company would approach Golden Triangle Angelnet, Dr. Mark Goldberg made a presentation on PlantForm Corporation Inc. and its work developing the manufacture of the cancer drug Herceptin from plants.
Dr. Mark Goldberg is an entrepreneur and is Chairman of the Board of PlantForm Corp.
Dr. Goldberg received a BSc (Hon.) in Biology from the University of Western Ontario and a PhD in Pharmacology from the Faculty of Medicine at Memorial University in 1980. He did his postdoctoral work in Biochemical and Genetic Toxicology at the Ontario Cancer Institute in Toronto. He joined the faculty in the Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph in 1982.
PlantForm Corp. is seeking 3/4 M$ for bringing the drug Herceptin to market by 2014, the year that the first patent on that drug runs out.